On Jan 5, 2022 Atom Bioscience & Pharmaceutical closed a Series C round and raised $45,000,000 from EFung Capital, Kaitai Capital, Livzon Pharmaceutical Group, Oriza Holdings, Sequoia Capital China, ShenZhen GTJA Investment Group, Unifortune, Xicheng Jinrui, featuring lead investors ShenZhen GTJA Investment Group, Xicheng Jinrui.

About the company: Atom Bioscience & Pharmaceutical is located at China, Asia.
“”

Company website: http://www.atombp.com